CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- 4 Open-market buy Director bought 2,370 shares at an average $10.42 ($24,689)
- 4 Open-market buy Exec. VP and COO bought 960 shares at $10.31 ($9,898)
- 4 Open-market buy Chief Executive Officer bought 965 shares at $10.34 ($9,980)
- 4 Open-market buy Director bought 3,000 shares at $10.95 ($32,850)
- 4 Open-market buy Director bought 3,000 shares at an average $10.55 ($31,660)
- 4 Open-market buy Director bought 1,500 shares at $9.27 ($13,898)
- 4 Shares withheld for taxes Exec. VP and COO gave up 31 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 113 shares (to pay taxes)
- 4 Open-market sale Exec. VP and COO sold 35,321 shares at $18.60 ($657,020)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 2,550 shares at an average $5.70 ($14,527)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 15 · 300 filings